National Health Expenditure Projections, 2021-30: Growth To Moderate As COVID-19 Impacts Wane

Although considerable uncertainty remains, the COVID-19 pandemic and public health emergency are expected to continue to influence the near-term outlook for national health spending and enrollment. National health spending growth is expected to have decelerated from 9.7 percent in 2020 to 4.2 percent in 2021 as federal supplemental funding was expected to decline substantially relative to 2020. Through 2024 health care use is expected to normalize after the declines observed in 2020, health insurance enrollments are assumed to evolve toward their prepandemic distributions, and the remaining federal supplemental funding is expected to wane. Economic growth is expected to outpace health spending growth for much of this period, leading the projected health share of gross domestic product (GDP) to decline from 19.7 percent in 2020 to just over 18 percent over the course of 2022-24. For 2025-30, factors that typically drive changes in health spending and enrollment, such as economic, demographic, and health-specific factors, are again expected to primarily influence trends in the health sector. By 2030 the health spending share of GDP is projected to reach 19.6 percent.

Automated summary

Despite remaining uncertainty, the COVID-19 pandemic is expected to continue impacting national health spending and enrollment in the near term. Health spending growth is projected to decelerate due to a decline in federal supplemental funding, with economic growth outpacing health spending growth for much of the period 2022-24, leading to a decrease in the health share of GDP to just over 18%.